Cullgen Inc.’s $50 Million Series B Financing

Wilson Sonsini Goodrich & Rosati advised Cullgen Inc. on the deal.Cullgen Inc., a leading biotechnology company developing small molecule therapeutics based on its proprietary uSMITE™ platform…

This content is for Standard 1 Year members only.
Login Join Now
Martina Bellini

Author: Martina Bellini

This content is for Standard 1 Year members only.
Login Join Now